Clinical Significance of Circulating Tumor Cells in Gastrointestinal Carcinomas
The idea of a liquid biopsy to screen, surveil and treat cancer patients is an intensively discussed and highly awaited tool in the field of oncology. Despite intensive research in this field, the clinical application has not been implemented yet and further research has to be conducted. However, on...
Main Authors: | Leonie Konczalla, Anna Wöstemeier, Marius Kemper, Karl-Frederik Karstens, Jakob Izbicki, Matthias Reeh |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-03-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/10/4/192 |
Similar Items
-
Circulating cell-free DNA and circulating tumor cells, the “liquid biopsies” in ovarian cancer
by: Xianliang Cheng, et al.
Published: (2017-11-01) -
Liquid Biopsy in Gastrointestinal Cancers
by: Aman Saini, et al.
Published: (2018-10-01) -
Cell-free circulating tumor DNA in cancer
by: Zhen Qin, et al.
Published: (2016-04-01) -
Evolving Clinical Utility of Liquid Biopsy in Gastrointestinal Cancers
by: Richard A. Jacobson, et al.
Published: (2019-08-01) -
Circulating Cell-Free DNA or Circulating Tumor DNA in the Management of Ovarian and Endometrial Cancer
by: Chen Q, et al.
Published: (2019-12-01)